USC News

Menu Wednesday, September 30, 2020 81° Clear

Michelson Center for Convergent Bioscience

Search
Science/Technology
GABAB receptor protein brain activity
A nerve cell synapse with structures GABAB, a neurotransmitter receptor protein, captured in four different conformations (background) and in the active state (close-up) with molecules (orange and magenta) bound to it. (Illustration/Yekaterina Kadyshevskaya)

Scientists discover how a protein that calms brain activity works

The findings from USC researchers provide a clear path to uncovering new drugs to control addiction, pain and neurological disorders such as epilepsy and muscle spasticity.

Science/TechnologyUniversity
Steve Kay
Steve Kay is director of the MESH (Medicine, Engineering, Sciences and Humanities) Academy, director of the USC Michelson Center for Convergent Bioscience and a Provost Professor of Neurology, Biomedical Engineering and Biological Sciences at the Keck School of Medicine of USC. (Photo/Max Gerber)

Steve Kay recognized for 25 years of studying circadian rhythms in plants

The decorated USC professor received an award from the Society for Research on Biological Rhythms for decades of research into the mustard plant.

HealthScience/Technology
postpartum bleeding drug activation
Some important conditions are treated by misoprostol, including ulcers, bleeding inflammation, pain and labor. Illustrated here is misoprostol in the binding site of the hormone prostaglandin E2 receptor 3. (Illustration/Yekaterina Kadyshevskaya)

Better drug to save mothers’ lives during childbirth may be on the way

Scientists at the USC Michelson Center for Convergent Bioscience and Stanford University take first step toward a safer drug for reducing postpartum bleeding.